TOP vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

TOP

57.2
AI Score
VS
TOP Wins

HIVE

40.6
AI Score

Investment Advisor Scores

TOP

57score
Recommendation
HOLD

HIVE

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TOP HIVE Winner
Revenue 79.12M 1.08M HIVE
Net Income -142.91M -113,433 TOP
Net Margin -180.6% -10.5% TOP
ROE -33.8% -0.3% TOP
ROA -15.5% -0.1% TOP
Total Assets 924.64M 158.41M HIVE
Cash 208.04M 10.41M HIVE

Relative Price Performance (Last 90 Days)

TOP 1M: -0.2% · 3M: +643.6% HIVE 1M: +9.7% · 3M: -11.7%

Current Technical Phase

TOP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (70.7% over 20 days), RSI 59

RSI (14): 59.3 · Price: $15.17

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 47

RSI (14): 46.8 · Price: $2.99

Fundamentals Snapshot

Metric TOP HIVE
Market Cap — —
Forward P/E 0.0 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.7%
Gross Margin 0.6% 0.4%
Operating Margin -0.4% -0.6%
EPS -0.18 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TOP is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.